Clinical Experiences of Cardiac Myxoma.
10.3349/ymj.2006.47.3.367
- Author:
Song Hyeon YU
1
;
Sang Hyun LIM
;
You Sun HONG
;
Kyung Jong YOO
;
Byung Chul CHANG
;
Meyun Shick KANG
Author Information
1. Department of Thoracic & Cardiovascular Surgery, Yonsei Cardiovascular Center, Yonsei University College of Medicine, Seoul, Korea. yshong@yumc.yonsei.ac.kr
- Publication Type:Original Article
- Keywords:
Myxoma;
surgical resection;
heart
- MeSH:
Treatment Outcome;
Postoperative Complications;
Myxoma/physiopathology/*surgery;
Middle Aged;
Male;
Humans;
Heart Neoplasms/physiopathology/*surgery;
Follow-Up Studies;
Female;
Child;
Aged, 80 and over;
Aged;
Adult;
Adolescent
- From:Yonsei Medical Journal
2006;47(3):367-371
- CountryRepublic of Korea
- Language:English
-
Abstract:
Although cardiac myxoma is rare, it is the most common primary cardiac tumor. Seventy-four cases of cardiac myxoma that were surgically treated in our center between August 1980 and February 2005 were retrospectively reviewed. The mean patient age was 50.4+/-15.0 (range 7-80) years, and 53 patients (71.6%) were female. The most common preoperative symptom, occurring in 44 patients, was dyspnea. The interval from onset of symptoms to surgery was 9 months. Seventy cases were located in the left atrium, 3 in the right atrium and 1 in the right ventricle. The myxoma in the right ventricle could not be resected completely, due to severe infiltration. Cardiopulmonary bypass and aortic cross clamp times were 100.4+/-37.1 and 64.8+/-29.8 minutes, respectively. There were no hospital deaths, and 7 patients suffered from postoperative complications including atrial fibrillation in 2 cases. During the follow up period (mean 105.7+/-73.6 months), there was no tumor recurrence and 6 late deaths that were not related to the underlying tumor. There was no evidence of tumor growth in the cases with incomplete resection during the 14-month follow-up. In conclusion, in this study there was no recurrence of tumors after complete resection and surgical resection is considered to be the curative method of treatment for cardiac myxoma.
